T2 Biosystems, Inc.

Ownership Transactions Reported by 17 Insiders

Symbol
TTOO on Nasdaq
Location
101 Hartwell Avenue, Lexington, MA

Insiders trading volume in the past year

T2 Biosystems, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
CR Group L.P. 10%+ Owner $741K May 9, 2024
Goldman Sachs & Co. Llc 10%+ Owner $662K Mar 24, 2020
Adrian M. Jones Director $662K Mar 24, 2020
Aparna Ahuja Chief Medical Officer $94.5K Feb 20, 2022
John McDonough Director $94.2K Jul 1, 2021
John J. Sperzel III Chairman, President & CEO, Director $77.2K Nov 4, 2024
Michael Terrence Gibbs General Counsel $29.9K Nov 4, 2024
Alec Barclay Chief Operations Officer $28.7K Apr 8, 2022
John Sprague Cfo $28.4K Nov 4, 2024
Brett A. Giffin Chief Commercial Officer $28.4K Nov 4, 2024
John W. Cumming Director $5.51K Nov 4, 2024
David B. Elsbree Director $4K -$133 -3.22% Nov 4, 2024
Laura Lee Adams Director $3.94K Nov 4, 2024
Ninfa Saunders Director $3.94K Nov 4, 2024
Robin Toft Director $3.94K Nov 4, 2024
Seymour Liebman Director $3.94K Nov 4, 2024
Thierry Bernard Director $1.15K Sep 15, 2023

Recent Insider Transactions by Companies or Individuals for T2 Biosystems, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.